Showing 11,141 - 11,160 results of 18,540 for search 'significantly ((((((lower decrease) OR (larger decrease))) OR (a decrease))) OR (linear decrease))', query time: 0.81s Refine Results
  1. 11141

    Image 2_Prediction of major adverse cardiovascular events following ST-segment elevation myocardial infarction using cardiac obesity marker—epicardial adipose tissue mass index: a... by Zeyan Liu (3748747)

    Published 2025
    “…Background<p>Although reperfusion therapy has led to improvements in the acute phase of ST-segment elevation myocardial infarction (STEMI), the incidence of major adverse cardiovascular events (MACE) following STEMI has not significantly decreased. The accumulation of epicardial adipose tissue (EAT) may be associated with poorer STEMI prognosis and could serve as a potential prognostic marker. …”
  2. 11142

    Image 5_Prediction of major adverse cardiovascular events following ST-segment elevation myocardial infarction using cardiac obesity marker—epicardial adipose tissue mass index: a... by Zeyan Liu (3748747)

    Published 2025
    “…Background<p>Although reperfusion therapy has led to improvements in the acute phase of ST-segment elevation myocardial infarction (STEMI), the incidence of major adverse cardiovascular events (MACE) following STEMI has not significantly decreased. The accumulation of epicardial adipose tissue (EAT) may be associated with poorer STEMI prognosis and could serve as a potential prognostic marker. …”
  3. 11143

    Image 1_Prediction of major adverse cardiovascular events following ST-segment elevation myocardial infarction using cardiac obesity marker—epicardial adipose tissue mass index: a... by Zeyan Liu (3748747)

    Published 2025
    “…Background<p>Although reperfusion therapy has led to improvements in the acute phase of ST-segment elevation myocardial infarction (STEMI), the incidence of major adverse cardiovascular events (MACE) following STEMI has not significantly decreased. The accumulation of epicardial adipose tissue (EAT) may be associated with poorer STEMI prognosis and could serve as a potential prognostic marker. …”
  4. 11144

    Image 3_Prediction of major adverse cardiovascular events following ST-segment elevation myocardial infarction using cardiac obesity marker—epicardial adipose tissue mass index: a... by Zeyan Liu (3748747)

    Published 2025
    “…Background<p>Although reperfusion therapy has led to improvements in the acute phase of ST-segment elevation myocardial infarction (STEMI), the incidence of major adverse cardiovascular events (MACE) following STEMI has not significantly decreased. The accumulation of epicardial adipose tissue (EAT) may be associated with poorer STEMI prognosis and could serve as a potential prognostic marker. …”
  5. 11145

    Data Sheet 1_Profile and risk factors of blood donors who experienced adverse reactions: a cross-sectional study on donor hemovigilance data reported to the national network from 2... by Junhong Yang (7807046)

    Published 2025
    “…Finally, donors from outdoor blood collection sites (0.590%) and groups (1.073%) were at a significantly higher risk of syncope compared to those from indoor blood donation sites (0.438%) and individual donors (0.174%).…”
  6. 11146

    Data_Sheet_1_Effects of COVID-19-targeted non-pharmaceutical interventions on pediatric hospital admissions in North Italian hospitals, 2017 to 2022: a quasi-experimental study int... by Giuseppe Maglietta (12992976)

    Published 2024
    “…ITS analysis confirms a high reduction of level change during school closure for Respiratory Diseases (HRR 0.19, 95%CI 0.08–0.47) and a similar but smaller significant reduction when mitigation measures were enacted. …”
  7. 11147

    Data_Sheet_1_Effects of COVID-19-targeted non-pharmaceutical interventions on pediatric hospital admissions in North Italian hospitals, 2017 to 2022: a quasi-experimental study int... by Giuseppe Maglietta (12992976)

    Published 2024
    “…ITS analysis confirms a high reduction of level change during school closure for Respiratory Diseases (HRR 0.19, 95%CI 0.08–0.47) and a similar but smaller significant reduction when mitigation measures were enacted. …”
  8. 11148

    Supplementary file 1_The evolution of the global disease burden of polycystic ovary syndrome and the role of regional heterogeneity in high body mass index exposure: a spatiotempor... by Ying Feng (151159)

    Published 2025
    “…In contrast, metabolic disease burden was significantly elevated in postmenopausal women, exhibiting a pattern distinct from that of PCOS.…”
  9. 11149

    Data Sheet 2_Comparative effectiveness and safety of sodium-glucose cotransporter 2 inhibitors vs glucagon-like peptide 1 receptor agonists in elderly patients with type 2 diabetes... by Yao Wang (102387)

    Published 2025
    “…Objective<p>This systematic review aimed to evaluate the cardiovascular effectiveness and safety of initiating sodium-glucose cotransporter 2 inhibitors (SGLT2i) in comparison to glucagon-like peptide 1 receptor agonists (GLP-1RA) among elderly patients with diabetes.</p>Methods<p>A comprehensive search of the PubMed, Embase, and Web of Science databases was conducted up to March 2024. …”
  10. 11150

    Data Sheet 1_Comparative effectiveness and safety of sodium-glucose cotransporter 2 inhibitors vs glucagon-like peptide 1 receptor agonists in elderly patients with type 2 diabetes... by Yao Wang (102387)

    Published 2025
    “…Objective<p>This systematic review aimed to evaluate the cardiovascular effectiveness and safety of initiating sodium-glucose cotransporter 2 inhibitors (SGLT2i) in comparison to glucagon-like peptide 1 receptor agonists (GLP-1RA) among elderly patients with diabetes.</p>Methods<p>A comprehensive search of the PubMed, Embase, and Web of Science databases was conducted up to March 2024. …”
  11. 11151

    PRISMA flow chart. by Adeniyi Adeboye (21763205)

    Published 2025
    “…Additionally, it increased self-efficacy (n = 267; <i>d,</i> 95% CI = 0.22, 0.00 to 0.44) and recovery (n = 285; <i>d,</i> 95% CI = 0.19, -0.02 to 0.41). However, there was a decrease in stigma resistance (n = 318; <i>d</i>, 95% CI = -0.13, -0.36 to 0.10). …”
  12. 11152

    Characteristics of included studies. by Adeniyi Adeboye (21763205)

    Published 2025
    “…Additionally, it increased self-efficacy (n = 267; <i>d,</i> 95% CI = 0.22, 0.00 to 0.44) and recovery (n = 285; <i>d,</i> 95% CI = 0.19, -0.02 to 0.41). However, there was a decrease in stigma resistance (n = 318; <i>d</i>, 95% CI = -0.13, -0.36 to 0.10). …”
  13. 11153

    EPHPP tool quality assessment results. by Adeniyi Adeboye (21763205)

    Published 2025
    “…Additionally, it increased self-efficacy (n = 267; <i>d,</i> 95% CI = 0.22, 0.00 to 0.44) and recovery (n = 285; <i>d,</i> 95% CI = 0.19, -0.02 to 0.41). However, there was a decrease in stigma resistance (n = 318; <i>d</i>, 95% CI = -0.13, -0.36 to 0.10). …”
  14. 11154

    Data Sheet 1_Virus-like particles containing the extracellular domain of G protein in combination with a CTL peptide of M2 elicit protection against respiratory syncytial virus inf... by Huan Qin (3511913)

    Published 2025
    “…Post-RSV challenge, mice vaccinated with G<sub>ECD</sub>/M2<sub>82-90</sub>-VLPs exhibited a substantially increased proportion of CD25<sup>+</sup>FoxP3<sup>+</sup> Treg cells and a decreased percentage of Th17 cells in the lungs. …”
  15. 11155

    Data Sheet 1_Cross-species analysis of FcγRIIa/b (CD32a/b) polymorphisms at position 131: structural and functional insights into the mechanism of IgG- mediated phagocytosis in hum... by William D. Tolbert (7870697)

    Published 2025
    “…Its affinity for IgG and ability to mediate ADCP is influenced by allelic polymorphisms. In humans, a single amino acid polymorphism at position 131, where histidine (H) is substituted with arginine (R), leads to decreased IgG1 and IgG2 subclass binding affinity and, consequently, lower efficiency of phagocytic responses. …”
  16. 11156
  17. 11157

    List of the cells used in this study. by Carsten Alexander Baltes (22190513)

    Published 2025
    “…We investigated the number and size of focal adhesions in RPE-1 cells and used single-cell force spectroscopy to evaluate the adhesion properties of those cells after MiuA treatment. We showed that MiuA increases the number of focal adhesions while decreasing their size and reduces adhesion energy and force. …”
  18. 11158

    S1 Data - by Amani S. Alghamdi (20500935)

    Published 2025
    “…The study concludes with significant insights into how the TLEC distribution provides a more accurate and flexible approach to modeling real-world phenomena.…”
  19. 11159

    S1 Appendix - by Amani S. Alghamdi (20500935)

    Published 2025
    “…The study concludes with significant insights into how the TLEC distribution provides a more accurate and flexible approach to modeling real-world phenomena.…”
  20. 11160

    Estimated CDFs for the recovered cases data. by Amani S. Alghamdi (20500935)

    Published 2025
    “…The study concludes with significant insights into how the TLEC distribution provides a more accurate and flexible approach to modeling real-world phenomena.…”